Sanara Medtech
Quarterly Financials
| Values in thousands | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|
Revenue | $25,830 | $23,434 | $26,305 | $21,671 |
Gross Profit | 22,779 | 21,599 | 24,056 | 19,679 |
EBITDA | 887 | 168 | 1,196 | -851 |
EBIT | -226 | -955 | -411 | -1,955 |
Net Income | -2,014 | -3,527 | -1,538 | -2,857 |
Net Change In Cash | 25,830 | 23,434 | 26,305 | 21,671 |
Free Cash Flow | 902 | -3,721 | 836 | 2,041 |
Cash | 16,958 | 20,687 | 15,878 | 16,277 |
Basic Shares | 8,612 | 8,570 | 8,531 | 8,517 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $86,672 | $64,989 | $45,842 | $24,143 |
Gross Profit | 78,532 | 57,137 | 39,481 | 21,832 |
EBITDA | -1,860 | -289 | -9,674 | -7,221 |
EBIT | -6,783 | -3,964 | -12,045 | -7,993 |
Net Income | -9,664 | -4,303 | -7,937 | -7,921 |
Net Change In Cash | 86,672 | 64,989 | 45,842 | 24,143 |
Cost of Revenue | -9,693 | |||
Free Cash Flow | -229 | -3,510 | -6,301 | -5,564 |
Cash | 15,878 | 5,147 | 8,958 | 18,652 |
Basic Shares | 8,484 | 8,278 | 7,906 | 7,341 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-09-30 | $0 |
2025-06-30 | -$0.23 |
2025-03-31 | -$0.41 |
2024-12-31 | -$0.18 |
